Literature DB >> 7354120

Vasopressin in human cerebrospinal fluid.

J S Jenkins, H M Mather, V Ang.   

Abstract

Arginine vasopressin was measured by RIA in samples of plasma and cerebrospinal fluid (CSF) taken synchronously from 62 patients with proven or suspected disorders of the central nervous system in order to determine the relationship between the secretion of vasopressin into the systemic circulation and that into the CSF. In 12 patients without endocrine or brain disease, mean plasma values (+/- SD) were 2.8 +/- 0.7 pg/ml and CSF values were 2.4 +/- 0.7 pg/ml. Thirty-six patients with various intracranial disorders had plasma and CSF values which were both within the range of 1-4 pg/ml. Eight patients had raised plasma concentrations, but their CSF levels were within the normal range. One patient with posttraumatic diabetes insipidus and 2 patients with subarachnoid hemorrhage had concentrations of CSF vasopressin which were greater than plasma levels. These results indicate that a blood CSF barrier to vasopressin exists in man and that under certain pathological conditions excessive amounts of the hormone can be secreted into the CSF independently of that which is released into the blood, a finding which could have clinical significance in disorders of brain function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354120     DOI: 10.1210/jcem-50-2-364

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.

Authors:  J Seckl; S Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

2.  Plasma and cerebrospinal fluid vasopressin and osmolality in relation to thirst.

Authors:  E Szczepańska-Sadowska; C Simon-Oppermann; D A Gray; E Simon
Journal:  Pflugers Arch       Date:  1984-03       Impact factor: 3.657

3.  Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.

Authors:  J Sundquist; M L Forsling; J E Olsson; M Akerlund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

4.  Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin.

Authors:  F A László; C Varga; T Dóczi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Raised intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, and arginine vasopressin in tuberculous meningitis.

Authors:  M F Cotton; P R Donald; J F Schoeman; L E Van Zyl; C Aalbers; C J Lombard
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

6.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

7.  Contractile effects of perivascularly applied vasopressin on the pial artery of the cat brain.

Authors:  M Nakai
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

8.  Arginine vasopressin concentrations in the cerebrospinal fluid of children.

Authors:  M F Cotton; P R Donald; C Aalbers
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

9.  Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage.

Authors:  H M Mather; V Ang; J S Jenkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.